BennuBio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

BennuBio General Information

Description

Developer of flow cytometer devices designed to facilitate monitoring and analysis of blood cells and particles. The company's devices help in cell counting, cell sorting, biomarker detection, and protein engineering by analyzing sample volumes from microliters to liters and particle sizes from a few micrometers to millimeters, enabling healthcare professionals to conduct immuno-oncology treatment through diagnosis in an efficient manner.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6610 Gulton Court North East
  • Albuquerque, NM 87109
  • United States
+1 (505)
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 6610 Gulton Court North East
  • Albuquerque, NM 87109
  • United States
+1 (505)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BennuBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 01-Oct-2025 Completed Generating Revenue
10. Accelerator/Incubator 01-Jun-2023 Completed Generating Revenue
9. Later Stage VC (Series B1) 30-Mar-2023 Completed Generating Revenue
8. Early Stage VC (Series B) 02-Mar-2022 Completed Generating Revenue
7. Grant 09-Feb-2022 Completed Generating Revenue
6. Grant 01-Aug-2021 Completed Generating Revenue
5. Grant 08-Jul-2020 Completed Generating Revenue
4. Early Stage VC (Series B) 20-Mar-2020 Completed Generating Revenue
3. Grant 09-Sep-2019 $500K $2M Completed Generating Revenue
2. Early Stage VC (Series A) 15-Feb-2019 $2M $2M Completed Generating Revenue
To view BennuBio’s complete valuation and funding history, request access »

BennuBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A 2,000,000 $0.000100 8% $1 $1 1x $1 15.56%
To view BennuBio’s complete cap table history, request access »

BennuBio Patents

BennuBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025259927-A1 Angled flow cells for flow cytometry Pending 12-Jun-2024
WO-2025259818-A1 Machined structures in anodically bonded thin metal layer acousto-optical flow cells Pending 12-Jun-2024
WO-2025217338-A1 Systems and methods of serial enrichment and dilution (sed) to sort target cells Pending 11-Apr-2024
GB-202217222-D0 Method and apparatus for large-scale spheroid generation Inactive 18-Feb-2020
GB-2610116-A Method and apparatus for large-scale spheroid generation Inactive 18-Feb-2020 B01J2/06
To view BennuBio’s complete patent history, request access »

BennuBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BennuBio Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioTools Innovator Accelerator/Incubator Minority
Chestnut Creek Partners Venture Capital Minority
Co-Win Ventures Venture Capital Minority
Cottonwood Technology Fund Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
You’re viewing 5 of 14 investors. Get the full list »

BennuBio Acquisitions (1)

BennuBio’s most recent deal was a Merger/Acquisition with Eta Diagnostics. The deal was made on 01-Jan-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Eta Diagnostics 01-Jan-2019 Merger/Acquisition Laboratory Services (Healthcare)
To view BennuBio’s complete acquisitions history, request access »

BennuBio FAQs

  • When was BennuBio founded?

    BennuBio was founded in 2018.

  • Where is BennuBio headquartered?

    BennuBio is headquartered in Albuquerque, NM.

  • What is the size of BennuBio?

    BennuBio has 11 total employees.

  • What industry is BennuBio in?

    BennuBio’s primary industry is Other Devices and Supplies.

  • Is BennuBio a private or public company?

    BennuBio is a Private company.

  • What is BennuBio’s current revenue?

    The current revenue for BennuBio is .

  • How much funding has BennuBio raised over time?

    BennuBio has raised $11.3M.

  • Who are BennuBio’s investors?

    BioTools Innovator, Chestnut Creek Partners, Co-Win Ventures, Cottonwood Technology Fund, and MedTech Innovator are 5 of 14 investors who have invested in BennuBio.

  • When was BennuBio acquired?

    BennuBio was acquired on 01-Oct-2025.

  • Who acquired BennuBio?

    BennuBio was acquired by Precision Cell Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process